文献速递先天性心脏病外科

非开窗心外管道Fontan手术24年结果及Fontan转换

24-Year Results of Nonfenestrated Extracardiac Fontan Including Fontan Conversions.
PubMed 文献 · Ann Thorac Surg · 2020-08-11

该研究回顾性分析1994至2018年单中心341例非开窗心外管道Fontan手术及Fontan转换患者,总体手术死亡率1.2%。多变量分析显示体外循环时间延长、术前主心室功能减低和住院时长与不良事件相关,术前轻及以上心室功能障碍降低生存率及无不良事件生存率。

要点

  • 非开窗心外管道Fontan手术总体手术死亡率低(1.2%)。
  • 术前心室功能障碍是生存及无不良事件生存的关键危险因素。
  • Fontan患者向心脏移植的 attrition 持续存在。

核心结论

  • 过去24年非开窗心外管道Fontan策略在初次Fontan和Fontan转换中均实现低手术死亡率。
  • Fontan患者向心脏移植的 attrition 持续存在,关键危险因素为术前心室功能障碍。

研究设计与样本

  • 共341例患者,其中初次心外管道非开窗Fontan完成手术193例(57%),Fontan转换148例(43%)。
  • 收集标准人口学数据、基础解剖、术前心室及瓣膜功能、手术细节、围术期数据和临床结局,并进行统计分析。

主要发现

  • 总体手术死亡4例(1.2%)。
  • 住院时长11天(SD,6天),呼吸机使用时长28小时(SD,26小时)。
  • 6例完成Fontan患者(3%)需要Fontan takedown,中位时间2.5天。
  • 多变量分析显示与不良事件(死亡、Fontan takedown和/或移植)相关的危险因素包括体外循环时间增加、术前主心室功能减低和住院时长。
  • Kaplan-Meier曲线显示术前轻或以上心室功能障碍降低初次心外管道Fontan和Fontan转换患者的生存率及无不良事件生存率。

临床怎么用

  • 非开窗心外管道Fontan可用于初次Fontan和Fontan转换,手术死亡率低。
  • 术前应评估心室功能,术前心室功能障碍患者需加强围术期管理及长期随访。

局限性

  • 回顾性单中心研究,结果可能受选择偏倚影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is active debate regarding the optimal method of Fontan palliation. In light of this, we reviewed our experience with the nonfenestrated extracardiac Fontan including Fontan conversion. METHODS: We performed a retrospective review of all nonfenestrated extracardiac Fontan and Fontan conversion operations at our institution from December 1, 1994 to December 31, 2018. Standard demographic data were collected, including underlying anatomy, preoperative ventricular and valvular function, operative details, perioperative data, and clinical outcomes. Statistical analysis included comparison between initial extracardiac Fontan patients and Fontan conversions, as well as analysis of risk factors for adverse outcomes. RESULTS: There were 341 patients with an overall operative mortality of 4 patients (1.2%). Of these, 193 were extracardiac nonfenestrated Fontan completion operations (57%) and 148 were Fontan conversions (43%). Length of stay was 11 days (SD, 6 days) with ventilator duration of 28 hours (SD, 26 hours). Six of the completion Fontan patients (3%) required Fontan takedown at a median time of 2.5 days. Upon multivariable analysis, risk factors associated with adverse events (mortality, Fontan takedown, and/or transplant) included increased cardiopulmonary bypass time, preoperative decreased dominant ventricular function, and length of stay. Kaplan-Meier curves demonstrated that mild or greater preoperative ventricular dysfunction decreased survival as well as freedom from adverse events for both initial extracardiac Fontan and Fontan conversion patients. CONCLUSIONS: Over the past 24 years, our strategy of nonfenestrated extracardiac Fontan has achieved low operative mortality for both initial Fontan and Fontan conversion. There is a steady attrition of Fontan patients to cardiac transplantation; the key risk factor is preoperative ventricular dysfunction.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Stephens EH, Talwar AA, Devlin PJ, et al. 24-Year Results of Nonfenestrated Extracardiac Fontan Including Fontan Conversions. Ann Thorac Surg. 2020. PMID: 32795523. doi:10.1016/j.athoracsur.2020.06.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。